Last reviewed · How we verify

Chinese Herbal Medication — Competitive Intelligence Brief

Chinese Herbal Medication (Chinese Herbal Medication) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunomodulator. Area: Immunology.

phase 2 Immunomodulator Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Chinese Herbal Medication (Chinese Herbal Medication) — Xiu-Min Li. Chinese herbal medication is used to modulate the immune system and reduce inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Chinese Herbal Medication TARGET Chinese Herbal Medication Xiu-Min Li phase 2 Immunomodulator
Iguratimod Tablets Iguratimod Tablets Wangjing Hospital, China Academy of Chinese Medical Sciences marketed Small-molecule immunomodulator NF-κB pathway; multiple cytokine targets
Thymosin Alpha Thymosin Alpha Second Affiliated Hospital, School of Medicine, Zhejiang University marketed Immunomodulator
Veregen only Veregen only University of Texas Southwestern Medical Center marketed Botanical extract / polyphenol immunomodulator
Lamivudine+Oxymatrine Capsules Lamivudine+Oxymatrine Capsules Southeast University, China marketed Nucleoside reverse transcriptase inhibitor + herbal immunomodulator Reverse transcriptase; oxymatrine targets multiple immune pathways (non-specific)
Comarum Palustre Comarum Palustre Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology marketed herbal immunomodulator
Total Glucosides Paeony Capsules Total Glucosides Paeony Capsules Sun Yat-sen University marketed Herbal extract immunomodulator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunomodulator class)

  1. Actavis Mid-Atlantic LLC · 1 drug in this class
  2. Active Biotech AB · 1 drug in this class
  3. Air Force Military Medical University, China · 1 drug in this class
  4. Astellas Pharma Inc · 1 drug in this class
  5. Bayer · 1 drug in this class
  6. Beijing Children's Hospital · 1 drug in this class
  7. Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 drug in this class
  8. Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri · 1 drug in this class
  9. Chang Gung Memorial Hospital · 1 drug in this class
  10. ALK-Abelló A/S · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chinese Herbal Medication — Competitive Intelligence Brief. https://druglandscape.com/ci/chinese-herbal-medication. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: